RWJF
XLRN

Robert Wood Johnson Foundation’s Acceleron Pharma XLRN Stock Holding History

Robert Wood Johnson Foundation’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,343
Closed -$52K – 6
2014
Q4 		$52K Buy
+1,343
New +$46.8K ﹤0.01% 4

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Robert Wood Johnson Foundation's XLRN Position: Q1 2015 in Review

Robert Wood Johnson Foundation sold out of Acceleron Pharma (XLRN) in Q1 2015, closing a stake of 1,343 shares — an estimated $52K sold.

Robert Wood Johnson Foundation first reported a position in XLRN in Q4 2014 and held it in 1 quarter. The position peaked at $52K in Q4 2014. 115 funds tracked by Wall St. Rank hold XLRN as of Q1 2015.

  • Robert Wood Johnson Foundation reported no remaining Acceleron Pharma position as of Q1 2015 after selling out during the quarter.
  • Robert Wood Johnson Foundation sold 1,343 Acceleron Pharma shares in Q1 2015, an estimated $52K.
  • Robert Wood Johnson Foundation first reported a position in Acceleron Pharma in Q4 2014 and held it in 1 quarter.
  • Robert Wood Johnson Foundation's Acceleron Pharma position peaked at $52K in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2015.

Based on Robert Wood Johnson Foundation's 13F filing for Q1 2015, filed 12 May 2015.